Tirofiban hydrochloride (BioDeep_00000653359)
代谢物信息卡片
化学式: C22H39ClN2O6S (494.22172240000003)
中文名称: 盐酸替罗非班
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O.O.Cl
InChI: 1H
描述信息
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents
D050299 - Fibrin Modulating Agents
D002317 - Cardiovascular Agents
同义名列表
1 个代谢物同义名
数据库引用编号
7 个数据库交叉引用编号
- ChEBI: CHEBI:9606
- KEGGdrug: D01029
- PubChem: 60946
- ChEMBL: CHEMBL3189072
- MeSH: Tirofiban
- CAS: 142373-60-2
- CAS: 150915-40-5
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- Jun Zhang, Xin Huang, Guoqing Wang, Xianjun Wang, Tao Zhang, Dong Wang, Lifeng Qi, Jiye Liang, Bing Li, Jianfeng Chu, Kai Li, Lili Sun, Yun Song, Wei Zhao, Meimei Zheng, Yao Meng, Hao Yin, Wei Wang, Ju Han. Efficacy and Safety of Tirofiban Before Stenting for Symptomatic Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.
Neurology.
2024 Apr; 102(7):e209217. doi:
10.1212/wnl.0000000000209217
. [PMID: 38489544] - Hongfei Sang, Zhihua Cao, Jie Du, Thanh N Nguyen, Jeffrey L Saver, An Mao, Raul G Nogueira, Zhaojun Tao, Simin Zhou, Qin Han, Dong Sun, Bo Lei, Shudong Liu, Guoyong Zeng, Congguo Yin, Dongjing Xie, Weidong Luo, Zhenglong Jin, Zhongming Qiu. Intravenous Tirofiban Versus Alteplase Before Endovascular Treatment in Acute Ischemic Stroke: A Pooled Analysis of the DEVT and RESCUE BT Trials.
Stroke.
2024 Apr; 55(4):856-865. doi:
10.1161/strokeaha.123.044562
. [PMID: 38362756] - Haiyan Xie, Ying Chen, Wukun Ge, Xiuping Xu, Chengjiang Liu, Zhiyong Lan, Yina Yang. Does Endovascular Thrombectomy(ET) plus tirofiban benefit stroke patients: A systematic review and meta-analysis.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
2024 Jan; 33(1):107494. doi:
10.1016/j.jstrokecerebrovasdis.2023.107494
. [PMID: 38035642] - Wenjie Zi, Jiaxing Song, Weilin Kong, Jiacheng Huang, Changwei Guo, Wencheng He, Yinquan Yu, Bo Zhang, Wanjie Geng, Xiaolin Tan, Yaoyu Tian, Zongtao Liu, Minghua Cao, Daoyou Cheng, Bo Li, Wenguo Huang, Junsheng Liu, Pengfei Wang, Zhou Yu, Hao Liang, Shuang Yang, Mingshan Tang, Wenhua Liu, Xianjun Huang, Shugai Liu, Yufeng Tang, Youlin Wu, Li Yao, Zhu Shi, Pengcheng He, Haojin Zhao, Zhuo Chen, Jun Luo, Yue Wan, Qiang Shi, Maorong Wang, De Yang, Xianglin Chen, Fang Huang, Jinlin Mu, Hao Li, Zhimin Li, Jingbang Zheng, Shunli Xie, Tieying Cai, Yuqi Peng, Weihua Xie, Zhongming Qiu, Chang Liu, Chengsong Yue, Linyu Li, Yan Tian, Dahong Yang, Jian Miao, Jie Yang, Jinrong Hu, Raul G Nogueira, Duolao Wang, Jeffrey L Saver, Fengli Li, Qingwu Yang. Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion.
The New England journal of medicine.
2023 Jun; 388(22):2025-2036. doi:
10.1056/nejmoa2214299
. [PMID: 37256974] - Chong Liu, Lu Yin, Yinqin Hu, Zhizhen Shi, Qiaoyan Zhu, Qian Xiao, Guoyi Li, Jiwei Cheng, Yangbo Hou. Analysis of risk factors for the efficacy of tirofiban in the treatment of acute ischemic stroke.
Neurological research.
2023 Jun; 45(6):538-543. doi:
10.1080/01616412.2022.2164447
. [PMID: 36599001] - Hongfei Sang, Jiacheng Huang, Bingwu Jiang, Qifeng Guo, Thanh N Nguyen, Mohamad Abdalkader, Qin Han, Simin Zhou, Zhaojun Tao, An Mao, Zhizhong Yan, Jie Du, Ying Jin, Chuming Huang, Tianzhu Liu, Wenlong Zhao, Gangfeng Gu, Li Wang, Shugai Liu, Shiwei Luo, Jie Pu, Jinrong Hu, Jie Yang, Fengli Li, Wenjie Zi, Xiaogang Hu, Zhongming Qiu. Association between intravenous tirofiban and intracranial hemorrhage in acute large vessel occlusion stroke: insight from the RESCUE BT randomized placebo-controlled trial.
Journal of neurology.
2023 Jan; ?(?):. doi:
10.1007/s00415-023-11579-4
. [PMID: 36697890] - Zhongming Qiu, Fengli Li, Hongfei Sang, Weidong Luo, Shuai Liu, Wenhua Liu, Zhangbao Guo, Huagang Li, Dong Sun, Wenguo Huang, Min Zhang, Min Zhang, Weipeng Dai, Peiyang Zhou, Wei Deng, Zhiming Zhou, Xianjun Huang, Bo Lei, Jinglun Li, Zhengzhou Yuan, Bo Song, Jian Miao, Shudong Liu, Zhenglong Jin, Guoyong Zeng, Hongliang Zeng, Junjie Yuan, Changming Wen, Yang Yu, Guangxiong Yuan, Junxiong Wu, Chen Long, Jun Luo, Zhenxuan Tian, Chong Zheng, Zhizhou Hu, Shouchun Wang, Tao Wang, Li Qi, Rongzong Li, Yue Wan, Yingbing Ke, Youlin Wu, Xiurong Zhu, Weilin Kong, Jiacheng Huang, Daizhou Peng, Mingze Chang, Hanming Ge, Zhonghua Shi, Zhizhong Yan, Jie Du, Ying Jin, Dongsheng Ju, Chuming Huang, Yifan Hong, Tianzhu Liu, Wenlong Zhao, Jian Wang, Bo Zheng, Li Wang, Shugai Liu, Xiaojun Luo, Shiwei Luo, Xinwei Xu, Jinrong Hu, Jie Pu, Shengli Chen, Yaxuan Sun, Shunfu Jiang, Liping Wei, Xinmin Fu, Yongjie Bai, Shunyu Yang, Wei Hu, Guling Zhang, Chengde Pan, Shuai Zhang, Yan Wang, Wenfeng Cao, Shiquan Yang, Jun Zhang, Fuqiang Guo, Hongbin Wen, Jinhua Zhang, Jiaxing Song, Chengsong Yue, Linyu Li, Deping Wu, Yan Tian, Jie Yang, Mengjie Lu, Jeffrey L Saver, Raul G Nogueira, Wenjie Zi, Qingwu Yang. Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.
JAMA.
2022 08; 328(6):543-553. doi:
10.1001/jama.2022.12584
. [PMID: 35943471] - Wei Tian, Taimin Zhang, Yan Gao, Zhangchao Yang, Hua Yang. Efficacy and safety assessment of urokinase plus tirofiban in acute cerebral infarction patients without clear criminal vessels.
Pakistan journal of pharmaceutical sciences.
2022 May; 35(3(Special)):878-883. doi:
. [PMID: 35791582]
- N Du, L-X Wang, Y-L Liu, X-L Yin, J-S Zhao, L Yang. Effect of tirofiban in treating patients with progressive ischemic stroke.
European review for medical and pharmacological sciences.
2022 03; 26(6):2098-2105. doi:
10.26355/eurrev_202203_28357
. [PMID: 35363359] - Rui Peng, Feng Li. The Clinical Efficacy of Tirofiban Combined with Ticagrelor and Aspirin in Treating Acute Myocardial Infarction by Percutaneous Coronary Intervention and Its Effect on Patients' Cardiac Function.
Journal of healthcare engineering.
2022; 2022(?):4708572. doi:
10.1155/2022/4708572
. [PMID: 35186231] - Fang Li, Shuhui Wang, Lei Wang, Feng Liu, Zhen Meng, Jia Liu. The Effects of Ticagrelor Combined with Tirofiban on Coagulation Function, Serum Myocardial Injury Markers, and Inflammatory Factor Levels in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention.
Computational and mathematical methods in medicine.
2022; 2022(?):4217270. doi:
10.1155/2022/4217270
. [PMID: 35529262] - Li Deng, Hai-Zhen Jia, Mao-Chun Li, Wei Zhu. Comparison of the effect of ticagrelor combined with tirofiban versus clopidogrel combined with tirofiban on inflammation response and prognosis of patients with unstable angina pectoris in long term follow-up.
The Kaohsiung journal of medical sciences.
2021 Nov; 37(11):1010-1015. doi:
10.1002/kjm2.12421
. [PMID: 34338425] - Wenbo Zhao, Jiali Xu, Sijie Li, Guiyou Liu, Longfei Wu, Chuanhui Li, Chuanjie Wu, Changhong Ren, Jian Chen, Jiangang Duan, Ruixian Wang, Haiqing Song, Qingfeng Ma, Xunming Ji. Low-dose tirofiban is associated with reduced in-hospital mortality in cardioembolic stroke patients treated with endovascular thrombectomy.
Journal of the neurological sciences.
2021 Aug; 427(?):117539. doi:
10.1016/j.jns.2021.117539
. [PMID: 34153842] - Bin Fu, Yun Chen, Ping Li. 2019 novel coronavirus disease with secondary ischemic stroke: two case reports.
BMC neurology.
2021 Jan; 21(1):4. doi:
10.1186/s12883-020-02033-3
. [PMID: 33397310] - Maoling Xu, Cun Zhang, Xiuzhen Yu, Lele Zhu, Hong Tan, Cong Wang, Lingshi Zhao, Zhihua Zhao. Application effect of tirofiban on percutaneous coronary intervention in patients with acute coronary syndrome and its postoperative effect on C-X-C motif chemokine ligand 16 level and myocardial perfusion.
Pakistan journal of pharmaceutical sciences.
2021 Jan; 34(1(Special)):465-472. doi:
. [PMID: 34275795]
- Salma Abdeladim, Mahassine Elharras, Amal Elouarradi, Ilham Bensahi, Sara Oualim, Fatimazahra Merzouk, Mohamed Sabry. Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases.
The Pan African medical journal.
2021; 38(?):9. doi:
10.11604/pamj.2021.38.9.27215
. [PMID: 33520078] - Pengfei Zhang, Yanting Guo, Jie Shen, Hongbin Li, Ruixian Wang, Ying Wang, Xiaojie Yu, Qingping Yao. Efficacy and safety of tirofiban therapy in patients receiving endovascular treatment after large vessel ischaemic stroke: A systematic review and meta-analysis.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia.
2020 Oct; 80(?):112-120. doi:
10.1016/j.jocn.2020.07.040
. [PMID: 33099332] - Maurizio Viecca, Dejan Radovanovic, Giovanni Battista Forleo, Pierachille Santus. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.
Pharmacological research.
2020 08; 158(?):104950. doi:
10.1016/j.phrs.2020.104950
. [PMID: 32450344] - Nicola Corcione, Martino Pepe, Paolo Ferraro, Alberto Morello, Sirio Conte, Raffaella Avellino, Elena Cavarretta, Eugenio Carulli, Giuseppe Biondi-Zoccai, Arturo Giordano. Impact of Tirofiban on Serum Troponin Changes in Patients Undergoing Carotid Artery Stenting: A Propensity Matched Analysis.
Annals of vascular surgery.
2020 Apr; 64(?):151-156.e2. doi:
10.1016/j.avsg.2019.09.011
. [PMID: 31629846] - Ming Yang, Xiaochuan Huo, Zhongrong Miao, Yongjun Wang. Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke.
Drugs.
2019 Apr; 79(5):515-529. doi:
10.1007/s40265-019-01078-0
. [PMID: 30838514] - Rajiv A Kabadi, Ilya M Danelich, John W Entwistle, Gregary D Marhefka, Gordon Reeves, Andrew J Boyle, Ataul M Qureshi. Use of Cangrelor as a Bridge to Left Ventricular Assist Device Implantation in a Patient with a Recent Drug-Eluting Stent Who Developed Acute Tirofiban-Related Thrombocytopenia.
Pharmacotherapy.
2019 04; 39(4):521-525. doi:
10.1002/phar.2219
. [PMID: 30644585] - Jiansong Huang, Xia Li, Xiaofeng Shi, Mark Zhu, Jinghan Wang, Shujuan Huang, Xin Huang, Huafeng Wang, Ling Li, Huan Deng, Yulan Zhou, Jianhua Mao, Zhangbiao Long, Zhixin Ma, Wenle Ye, Jiajia Pan, Xiaodong Xi, Jie Jin. Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting.
Journal of hematology & oncology.
2019 03; 12(1):26. doi:
10.1186/s13045-019-0709-6
. [PMID: 30845955] - Shih-Tai Chang, Ya-Ting Yang, Chi-Ming Chu, Kuo-Li Pan, Jen-Te Hsu, Ju-Feng Hsiao, Yu-Sheng Lin, Chang-Min Chung. Protein kinases are involved in the cardioprotective effects activated by platelet glycoprotein IIb/IIIa inhibitor tirofiban at reperfusion in rats in vivo.
European journal of pharmacology.
2018 Aug; 832(?):33-38. doi:
10.1016/j.ejphar.2018.05.014
. [PMID: 29778748] - Elizabeth A Walker, William E Dager. Bridging with Tirofiban during Oral Antiplatelet Interruption: A Single-Center Case Series Analysis Including Patients on Hemodialysis.
Pharmacotherapy.
2017 Aug; 37(8):888-892. doi:
10.1002/phar.1956
. [PMID: 28543216] - Lan Li, Zhenrong Ge, Dengke Zhang, Jun Kuang, Xiang Ma, Shubin Jiang. Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention.
Drug design, development and therapy.
2017; 11(?):3299-3307. doi:
10.2147/dddt.s138714
. [PMID: 29200825] - Duo-Duo Ding, Yue-Hu Wang, Ya-Hui Chen, Ren-Qiang Mei, Jun Yang, Ji-Feng Luo, Yan Li, Chun-Lin Long, Yi Kong. Amides and neolignans from the aerial parts of Piper bonii.
Phytochemistry.
2016 Sep; 129(?):36-44. doi:
10.1016/j.phytochem.2016.07.004
. [PMID: 27452451] - Pim Gal, Emel Parlak, Dirk A A M Schellings, Rypko Beukema, Jurriën ten Berg, Ahmet Adiyaman, Arnoud W J van 't Hof, Arif Elvan. Association of serial high sensitivity troponin T with onset of atrial fibrillation in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
European heart journal. Acute cardiovascular care.
2016 Feb; 5(1):33-42. doi:
10.1177/2048872615570220
. [PMID: 25694509] - Weiwei Guan, Zhen Wang, Yukai Liu, Yu Han, Hongmei Ren, Wei Eric Wang, Jian Yang, Lin Zhou, Chunyu Zeng. Protective effects of tirofiban on ischemia/reperfusion-induced renal injury in vivo and in vitro.
European journal of pharmacology.
2015 Aug; 761(?):144-52. doi:
10.1016/j.ejphar.2015.05.009
. [PMID: 25981297] - Shih-Tai Chang, Chang-Min Chung, Chi-Ming Chu, Teng-Yao Yang, Kuo-Li Pan, Jen-Te Hsu, Ju-Feng Hsiao. Platelet Glycoprotein IIb/IIIa Inhibitor Tirofiban Ameliorates Cardiac Reperfusion Injury.
International heart journal.
2015 May; 56(3):335-40. doi:
10.1536/ihj.14-322
. [PMID: 25912900] - Prabha Nini Gupta, Jinesh Thomas, Preetham Kumar Francis, Sajith Vamadevan Shylaja. +Ophitoxaemia and myocardial infarction--the issues during primary angioplasty: a review.
BMJ case reports.
2014 Oct; 2014(?):. doi:
10.1136/bcr-2013-201912
. [PMID: 25342187] - Tian-qi Zhu, Qi Zhang, Feng-hua Ding, Jian-ping Qiu, Hui-geng Jin, Li Jiang, Lin Lu, Rui-yan Zhang, Jian Hu, Zhen-kun Yang, Ying Shen, Wei-feng Shen. Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trial.
Chinese medical journal.
2013 Aug; 126(16):3079-86. doi:
. [PMID: 23981616]
- Tian Qi Zhu, Qi Zhang, Jian Ping Qiu, Hui Geng Jin, Lin Lu, Jie Shen, Liang Ping Zhao, Rui Yan Zhang, Jian Hu, Zhen Kun Yang, Wei Feng Shen. Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study.
International journal of cardiology.
2013 May; 165(3):437-43. doi:
10.1016/j.ijcard.2011.08.082
. [PMID: 21940058] - Duane B Lakings, Michael C Janzen, David J Schneider. Pharmacokinetic modeling of the high-dose bolus regimen of tirofiban in patients with severe renal impairment.
Coronary artery disease.
2012 May; 23(3):208-14. doi:
10.1097/mca.0b013e328351556e
. [PMID: 22441136] - Balakrishnan Sivaraman, Robert A Latour. Delineating the roles of the GPIIb/IIIa and GP-Ib-IX-V platelet receptors in mediating platelet adhesion to adsorbed fibrinogen and albumin.
Biomaterials.
2011 Aug; 32(23):5365-70. doi:
10.1016/j.biomaterials.2011.04.011
. [PMID: 21529934] - Szu-Chia Chen, Jia-Ling Ruan, Po-Wen Cheng, Yueh-Hsun Chuang, Pai-Chi Li. In vitro evaluation of ultrasound-assisted thrombolysis using a targeted ultrasound contrast agent.
Ultrasonic imaging.
2009 Oct; 31(4):235-46. doi:
10.1177/016173460903100402
. [PMID: 20458876] - Zhenxian Yan, Yujie Zhou, Yingxin Zhao, Yueping Li, Xiaomin Nie, Zhiming Zhou, Dean Jia. Efficacy and safety of tirofiban in high-risk patients with non-ST-segment elevation acute coronary syndromes.
Clinical cardiology.
2009 Sep; 32(9):E40-4. doi:
10.1002/clc.20475
. [PMID: 19645039] - Andreas C Eriksson, Per A Whiss. Characterization of static adhesion of human platelets in plasma to protein surfaces in microplates.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
2009 Apr; 20(3):197-206. doi:
10.1097/mbc.0b013e328327353d
. [PMID: 19657317] - Mahboob Alam, Rafael Gonzalez, Ariel Delarosa, Jaromir Bobek, Hisham Dokainish, Nasser Lakkis. In vitro inhibition of platelet aggregation in response to increasing concentrations of tirofiban in patients with significant renal insufficiency.
The American heart hospital journal.
2009; 7(1):17-20. doi:
10.15420/ahhj.2009.7.1.17
. [PMID: 19742428] - Zaccaria Ricci, Claudio Ronco. Year in review 2008: Critical Care--nephrology.
Critical care (London, England).
2009; 13(5):227. doi:
10.1186/cc7961
. [PMID: 19863769] - Martin D Thomas, Clare Wood, Mike Lovett, Lawrence Dembo, Gerry O'Driscoll. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
2008 Aug; 27(8):925-7. doi:
10.1016/j.healun.2008.05.015
. [PMID: 18656810] - U Boeken, J Litmathe, M Kurt, P Feindt, E Gams. CABG-procedures in patients with pretreatment with the GPIIb/IIIa-receptor antagonist tirofiban (Aggrastat): modification of perioperative management?.
International journal of cardiology.
2008 Jul; 127(2):257-9. doi:
10.1016/j.ijcard.2007.02.062
. [PMID: 17466394] - I Anita Jagroop, Dimitri P Mikhailidis. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
2008 Jul; 14(3):295-302. doi:
10.1177/1076029608316014
. [PMID: 18445610] - Daniel Sacristán, Antonio José López-Farré, José Javier Zamorano-León, Luis Azcona, Antonio Fernández-Ortiz, José Romero, Jerónimo Farré, Carlos Macaya. Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation.
Journal of cardiovascular pharmacology.
2008 Mar; 51(3):286-92. doi:
10.1097/fjc.0b013e318163a90f
. [PMID: 18356694] - Dalton S McLean, Shmuel Ravid, Michael Blazing, Bernard Gersh, Amy Shui, Christopher P Cannon. Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials.
American heart journal.
2008 Feb; 155(2):298-302. doi:
10.1016/j.ahj.2007.10.024
. [PMID: 18215600] - Andreas Link, Matthias Girndt, Simina Selejan, Ranja Rbah, Michael Böhm. Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study.
Critical care (London, England).
2008; 12(4):R111. doi:
10.1186/cc6998
. [PMID: 18759963] - Christian Storm, Achim Jörres. Does tirofiban prevent platelet loss in patients after cardiogenic shock during continuous renal replacement therapy?.
Critical care (London, England).
2008; 12(6):193. doi:
10.1186/cc7083
. [PMID: 19040776] - Sabina A Murphy, Christopher P Cannon, Stephen D Wiviott, James A de Lemos, Michael A Blazing, Carolyn H McCabe, Robert M Califf, Eugene Braunwald. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
The American journal of cardiology.
2007 Oct; 100(7):1047-51. doi:
10.1016/j.amjcard.2007.04.053
. [PMID: 17884359] - Nathaniel J Madsen, Chris E Holmes, Feliciano A Serrano, Burton E Sobel, David J Schneider. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
The American journal of cardiology.
2007 Aug; 100(4):722-7. doi:
10.1016/j.amjcard.2007.03.091
. [PMID: 17697836] - Hon-Kan Yip, Ali A Youssef, Li-Teh Chang, Cheng-Hsu Yang, Jiunn-Jye Sheu, Sarah Chua, Kuo-Ho Yeh, Fan-Yen Lee, Chiung-Jen Wu, Chi-Ling Hang. Association of interleukin-10 level with increased 30-day mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.
Circulation journal : official journal of the Japanese Circulation Society.
2007 Jul; 71(7):1086-91. doi:
10.1253/circj.71.1086
. [PMID: 17587715] - Victor Serebruany, Alex Malinin, Alex Pokov, Umesh Arora, Dan Atar, Dominick Angiolillo. Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?.
Thrombosis research.
2007; 119(2):175-81. doi:
10.1016/j.thromres.2006.02.004
. [PMID: 16546241] - Luca Pontiggia, Beat Steiner, Hans Ulrichts, Hans Deckmyn, Marc Forestier, Jürg H Beer. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba.
Thrombosis and haemostasis.
2006 Dec; 96(6):774-80. doi:
. [PMID: 17139372]
- Karen P Alexander, Anita Y Chen, L Kristin Newby, Janice B Schwartz, Rita F Redberg, Judith S Hochman, Matthew T Roe, W Brian Gibler, E Magnus Ohman, Eric D Peterson. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative.
Circulation.
2006 Sep; 114(13):1380-7. doi:
10.1161/circulationaha.106.620815
. [PMID: 16982940] - David A Morrow, James A de Lemos, Marc S Sabatine, Stephen D Wiviott, Michael A Blazing, Amy Shui, Nader Rifai, Robert M Califf, Eugene Braunwald. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.
Circulation.
2006 Jul; 114(4):281-8. doi:
10.1161/circulationaha.106.628909
. [PMID: 16847150] - Orsolya Tóth, Csaba Szabó, Marianna Kecskés, László Pótó, Agnes Nagy, Hajna Losonczy. In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters.
Life sciences.
2006 Jun; 79(4):317-23. doi:
10.1016/j.lfs.2006.01.007
. [PMID: 16480745] - M Parikka, L Nissinen, T Kainulainen, L Bruckner-Tuderman, T Salo, J Heino, K Tasanen. Collagen XVII promotes integrin-mediated squamous cell carcinoma transmigration--a novel role for alphaIIb integrin and tirofiban.
Experimental cell research.
2006 May; 312(8):1431-8. doi:
10.1016/j.yexcr.2006.01.015
. [PMID: 16487966] - Tze-Wen Chung, Min-Chia Yang, Wei-Jean Tsai. A fibrin encapsulated liposomes-in-chitosan matrix (FLCM) for delivering water-soluble drugs. Influences of the surface properties of liposomes and the crosslinked fibrin network.
International journal of pharmaceutics.
2006 Mar; 311(1-2):122-9. doi:
10.1016/j.ijpharm.2005.12.038
. [PMID: 16446064] - Stephen D Wiviott, James A de Lemos, Christopher P Cannon, Michael Blazing, Sabina A Murphy, Carolyn H McCabe, Robert Califf, Eugene Braunwald. A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
Circulation.
2006 Mar; 113(11):1406-14. doi:
10.1161/circulationaha.105.586347
. [PMID: 16534008] - Sorella Ilveskero, Riitta Lassila. Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists.
Thrombosis research.
2006; 117(3):291-7. doi:
10.1016/j.thromres.2005.03.013
. [PMID: 15878612] - M Feuring, J Harenberg, A Peiter, A Ganschow, A Ruf, R Losel, M Wehling, A Schultz. Impact of ABO blood groups on tirofiban mediated inhibition of platelet function.
Platelets.
2005 Nov; 16(7):430-4. doi:
10.1080/09537100500181889
. [PMID: 16236604] - Lori A Bailey, Joseph J Sistino, Walter E Uber. Is platelet function as measured by Thrombelastograph monitoring in whole blood affected by platelet inhibitors?.
The journal of extra-corporeal technology.
2005 Mar; 37(1):43-7. doi:
NULL
. [PMID: 15804156] - K A Tanaka, N Katori, F Szlam, N Sato, A B Kelly, J H Levy. Effects of tirofiban on haemostatic activation in vitro.
British journal of anaesthesia.
2004 Aug; 93(2):263-9. doi:
10.1093/bja/aeh193
. [PMID: 15194626] - R Oertel, A Köhler, A Koster, W Kirch. Determination of Tirofiban in human serum by liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2004 Jun; 805(1):181-5. doi:
10.1016/j.jchromb.2004.03.003
. [PMID: 15113556] - Hon-Kan Yip, Mien-Cheng Chen, Hsueh-Wen Chang, Fan-Ying Kuo, Cheng-Hsu Yang, Shyh-Ming Chen, Wei-Chin Hung, Chien-Jen Chen, Cheng-I Cheng, Chiung-Jen Wu. Transradial application of PercuSurge GuardWire device during primary percutaneous intervention of infarct-related artery with high-burden thrombus formation.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
2004 Apr; 61(4):503-11. doi:
10.1002/ccd.10685
. [PMID: 15065147] - Sen-Shyong Jeng, Ming-Shyong Wang. Isolation of a Zn-binding protein mediating cell adhesion from common carp.
Biochemical and biophysical research communications.
2003 Oct; 309(4):733-42. doi:
10.1016/j.bbrc.2003.08.060
. [PMID: 13679033] - S Goto, N Tamura, M Li, M Handa, Y Ikeda, S Handa, Z M Ruggeri. Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity.
Journal of thrombosis and haemostasis : JTH.
2003 Sep; 1(9):2022-30. doi:
10.1046/j.1538-7836.2003.00349.x
. [PMID: 12941046] - Martin Moser, Ulf Bertram, Karlheinz Peter, Christoph Bode, Johannes Ruef. Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates.
Journal of cardiovascular pharmacology.
2003 Apr; 41(4):586-92. doi:
10.1097/00005344-200304000-00011
. [PMID: 12658060] - Vladimir Rukshin, Babak Azarbal, Ariel Finkelstein, Prediman K Shah, Bojan Cercek, Vivian Tsang, Sanjay Kaul. Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis.
Journal of cardiovascular pharmacology.
2003 Apr; 41(4):615-24. doi:
10.1097/00005344-200304000-00015
. [PMID: 12658064] - Marc S Sabatine, Elliott M Antman. The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology.
2003 Feb; 41(4 Suppl S):89S-95S. doi:
10.1016/s0735-1097(02)03019-x
. [PMID: 12644346] - Giulia Renda, Bianca Rocca, Roberto Crocchiolo, Raimondo De Cristofaro, Raffaele Landolfi. Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban.
Thrombosis and haemostasis.
2003 Feb; 89(2):348-54. doi:
10.1055/s-0037-1613452
. [PMID: 12574816] - Daniel W Bougie, Peter R Wilker, Elizabeth D Wuitschick, Brian R Curtis, Mohammad Malik, Stewart Levine, Richard N Lind, Jaime Pereira, Richard H Aster. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.
Blood.
2002 Sep; 100(6):2071-6. doi:
NULL
. [PMID: 12200368] - Jeffrey T W Pang, Stephen Fort, Anthony Della Siega, Eric A Cohen. Emergency coronary artery bypass surgery in the era of glycoprotein IIb/IIIa receptor antagonist use.
Journal of cardiac surgery.
2002 Sep; 17(5):425-31. doi:
10.1111/j.1540-8191.2001.tb01172.x
. [PMID: 12630543] - James L Januzzi, Steven M Snapinn, Peter M DiBattiste, Ik-Kyung Jang, Pierre Theroux. Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.
Circulation.
2002 May; 105(20):2361-6. doi:
10.1161/01.cir.0000016359.94919.16
. [PMID: 12021221] - You Fu Li, Frederick A Spencer, Richard C Becker. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition.
American heart journal.
2002 Apr; 143(4):725-32. doi:
10.1067/mhj.2002.120299
. [PMID: 11923812] - Kazunao Kondo, Kazuo Umemura. Clinical pharmacokinetics of tirofiban, a nonpeptide glycoprotein IIb/IIIa receptor antagonist: comparison with the monoclonal antibody abciximab.
Clinical pharmacokinetics.
2002; 41(3):187-95. doi:
10.2165/00003088-200241030-00003
. [PMID: 11929319] - C Otto, M Baumann, T Schreiner, G Bartsch, H Borberg, P Schwandt, H Schmid-Schönbein. Standardized ultrasound as a new method to induce platelet aggregation: evaluation, influence of lipoproteins and of glycoprotein IIb/IIIa antagonist tirofiban.
European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.
2001 Dec; 14(2-3):157-66. doi:
10.1016/s0929-8266(01)00157-4
. [PMID: 11704433] - F Bizzarri, S Scolletta, E Tucci, M Lucidi, G Davoli, T Toscano, E Neri, L Muzzi, G Frati. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
The Journal of thoracic and cardiovascular surgery.
2001 Dec; 122(6):1181-5. doi:
10.1067/mtc.2001.117838
. [PMID: 11726894] - J J Popma, J Suk. Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction.
The American journal of cardiology.
2001 Oct; 88(8A):25K-29K. doi:
10.1016/s0002-9149(01)02037-9
. [PMID: 11694216] - D J Kereiakes, T Lorenz, J J Young, G Kukielka, M N Mueller, L Nanniazzi-Alaimo, D R Phillips. Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban.
Journal of thrombosis and thrombolysis.
2001 Oct; 12(2):123-7. doi:
10.1023/a:1012991303381
. [PMID: 11729363] - T Sudo, H Ito, Y Ozeki, Y Kimura. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
British journal of pharmacology.
2001 Aug; 133(8):1396-404. doi:
10.1038/sj.bjp.0704204
. [PMID: 11498527] - Y F Li, F A Spencer, R C Becker. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (alphaIIb/beta3) receptor-directed platelet inhibition.
American heart journal.
2001 Aug; 142(2):204-10. doi:
10.1067/mhj.2001.116962
. [PMID: 11479455] - B O King, E S Whittow, D L Serna, B U Jones, J S Eng, J C Chen. Tirofiban administration attenuates platelet and platelet-neutrophil conjugation but not neutrophil degranulation during in vitro VAD circulation.
ASAIO journal (American Society for Artificial Internal Organs : 1992).
2001 May; 47(3):282-7. doi:
10.1097/00002480-200105000-00025
. [PMID: 11374774] - J L Januzzi, C U Chae, M S Sabatine, I K Jang. Elevation in serum troponin I predicts the benefit of tirofiban.
Journal of thrombosis and thrombolysis.
2001 May; 11(3):211-5. doi:
10.1023/a:1011956703031
. [PMID: 11577259] - R A O'Rourke, J S Hochman, M C Cohen, C L Lucore, J J Popma, C P Cannon. New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction.
Archives of internal medicine.
2001 Mar; 161(5):674-82. doi:
10.1001/archinte.161.5.674
. [PMID: 11231699] - J Auer, R Berent, E Maurer, H Mayr, T Weber, B Eber. [Acute coronary syndromes: an update. I. Pathogenesis and drug therapy].
Herz.
2001 Mar; 26(2):99-110. doi:
10.1007/pl00002018
. [PMID: 11349620] - S J Marciniak, R E Jordan, M A Mascelli. Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban.
Thrombosis and haemostasis.
2001 Mar; 85(3):539-43. doi:
. [PMID: 11307828]
- M Cohen. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes.
The Journal of invasive cardiology.
2000 Dec; 12 Suppl E(?):E5-9;discussion E25. doi:
NULL
. [PMID: 11156722] - A Koster, M Loebe, F Mertzlufft, H Kuppe, R Hetzer. Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant.
The Annals of thoracic surgery.
2000 Dec; 70(6):2160-1. doi:
10.1016/s0003-4975(00)01888-9
. [PMID: 11156147] - J L Januzzi, S S Hahn, C U Chae, R Giugliano, K Lewandrowski, P Theroux, I K Jang. Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes.
The American journal of cardiology.
2000 Oct; 86(7):713-7. doi:
10.1016/s0002-9149(00)01068-7
. [PMID: 11018188] - S A Mousa, J M Bozarth, M S Forsythe, A Slee. Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levels.
Cardiovascular research.
2000 Sep; 47(4):819-26. doi:
10.1016/s0008-6363(00)00150-4
. [PMID: 10974231] - T Shimazaki, S Goto, M Sakakibara, K Eto, J Y Kim, N Ichikawa, M Yoshida, Y Nagaoka, T Isshiki, S Handa. [Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
Journal of cardiology.
2000 Aug; 36(2):113-21. doi:
. [PMID: 10955255]
- D J Kereiakes, J P Runyon, T M Broderick, T M Shimshak. IIb's are not IIb's.
The American journal of cardiology.
2000 Apr; 85(8A):23C-31C. doi:
10.1016/s0002-9149(00)00876-6
. [PMID: 10793177] - D J Kereiakes, T M Broderick, E M Roth, D Whang, M Mueller, P Lacock, L C Anderson, W Howard, C Blanck, J Schneider, C A Abbottsmith. High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonists.
Journal of thrombosis and thrombolysis.
2000 Feb; 9(2):149-55. doi:
10.1023/a:1018718914065
. [PMID: 10613996] - E Braunwald, R M Califf, C P Cannon, K A Fox, V Fuster, W B Gibler, R A Harrington, S B King, N S Kleiman, P Theroux, E J Topol, F Van de Werf, H D White, J T Willerson. Redefining medical treatment in the management of unstable angina.
The American journal of medicine.
2000 Jan; 108(1):41-53. doi:
10.1016/s0002-9343(99)00416-7
. [PMID: 11059440] - M Cohen, P Théroux, S Weber, P Laramée, T Huynh, S Borzak, J G Diodati, I B Squire, L I Deckelbaum, A R Thornton, K E Harris, F L Sax, M W Lo, H D White. Combination therapy with tirofiban and enoxaparin in acute coronary syndromes.
International journal of cardiology.
1999 Dec; 71(3):273-81. doi:
10.1016/s0167-5273(99)00171-0
. [PMID: 10636535] - S Vickers, A D Theoharides, B Arison, S K Balani, D Cui, C A Duncan, J D Ellis, L M Gorham, S L Polsky, T Prueksaritanont, H G Ramjit, D E Slaughter, K P Vyas. In vitro and in vivo studies on the metabolism of tirofiban.
Drug metabolism and disposition: the biological fate of chemicals.
1999 Nov; 27(11):1360-6. doi:
NULL
. [PMID: 10534322] - C M Dyke. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
American heart journal.
1999 Oct; 138(4 Pt 2):307-16. doi:
10.1053/hj.1999.v138.a100460
. [PMID: 10502236] - I Fisher, P Robinson, J M Ritter. Platelet glycoprotein IIb/IIIa blockade with tirofiban: effect on aggregation caused by P256, an antibody to human IIb/IIIa receptors.
British journal of clinical pharmacology.
1999 Aug; 48(2):197-9. doi:
10.1046/j.1365-2125.1999.00990.x
. [PMID: 10417496] - C Dyke, D Bhatia. Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous coronary revascularization. Management strategies for the cardiac surgeon.
The Journal of cardiovascular surgery.
1999 Aug; 40(4):505-16. doi:
NULL
. [PMID: 10532207] - Y Matsumoto, K Marukawa, H Okumura, T Adachi, T Tani, Y Kimura. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses.
Thrombosis research.
1999 Jul; 95(1):19-29. doi:
10.1016/s0049-3848(98)00189-3
. [PMID: 10403683]